Optimizing Implementation of Long Acting Injectable PrEP

Sponsor
University of Minnesota
Study ID
NCT07649551
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Plan-Do-Study-Act — BEHAVIORAL
    Implementation strategy of conducting cyclical small tests of change using Plan-Do-Study-Act

Study Details

Our goal is to optimize LAI-PrEP implementation within the context of other PrEP methods. Our strategy is flexible to allow pivot to include forthcoming PrEP dosing options should they become available

Key Dates

First listed
Jun 16, 2026
Start date
Jan 1, 2027
Status verified
Jun 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
20 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Active Comparator: Clinic Implementation
    We will implement changes responsive to current obstacles to LAI-PrEP care delivery with serial systematic evaluation. Preliminary impact of LAI-PrEP implementation will be evaluated using RE-AIM, assessing Reach, Effectiveness, Adoption, Implementation, and Maintenance via electronic medical records review, survey, and exit interviews. Exit interviews will also determine feasibility, acceptability, and appropriateness of Plan-Do-Study-Act as a clinic-based implementation strategy.
  • No Intervention: Control
    Observational control period

Primary Outcome Measure

LAI-PrEP prescribing [ Time Frame: 3 months ]

Central Contacts

Find similar trials

Nationwide
HIV trialsInfectious disease trials

Related Studies